Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within the existing legal framework by rigorously enforcing the provisions of the Clinical Establishments (Registration and Regulation) Act, 2010.

According to an official communication issued by the Union Ministry of Health and Family Welfare, states have been asked to immediately step up implementation of the Act, which mandates registration, minimum standards for infrastructure, staff, and services, and periodic inspections of all clinical establishments — from small nursing homes to large corporate hospitals.

A key focus of the directive is the introduction and enforcement of standardised package rates for common medical procedures and treatments across hospitals. The Centre has emphasised that uniform pricing will protect patients from arbitrary and inflated bills, especially in cases involving health insurance. This step is expected to curb the practice of overcharging and ensure that patients receive fair and predictable treatment costs irrespective of the hospital they choose.

The communication also highlights the urgent need for stronger grievance redressal mechanisms to resolve disputes involving hospitals, insurance companies, and patients. States have been instructed to set up or strengthen dedicated cells or online portals for timely handling of complaints related to overbilling, denial of insurance claims, quality of care, and unethical practices. The Centre has stressed that these mechanisms should be accessible, transparent, and time-bound to build greater trust in the healthcare ecosystem.

The directive comes amid growing concerns over rising out-of-pocket healthcare expenses and frequent conflicts between stakeholders in the insurance sector. By working strictly within the existing provisions of the Clinical Establishments Act, the government aims to achieve better regulation without requiring new legislation.

All states have been asked to submit action-taken reports within the next two months, detailing steps taken to enforce the Act, implement standardised rates, and operationalise robust grievance redressal systems. The Centre has assured full technical and financial support to states for capacity building and digital infrastructure required for effective implementation.

This initiative is being seen as a major step towards making quality healthcare more affordable and accountable for millions of patients across the country.

Related Posts

Annovis Bio receives US patent covering new crystalline form of buntanetap

Annovis Bio, Inc. (Annovis), a phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), announced that…

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

The enforcement wing of Karnataka’s Food Safety and Drugs Control Department has seized medical devices and consumables worth ₹13.79 lakh from two establishments in Bengaluru’s Cottonpet area for alleged violations…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Annovis Bio receives US patent covering new crystalline form of buntanetap

Annovis Bio receives US patent covering new crystalline form of buntanetap

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels